Skip to content

Omalizumab

Also known as Xolair (us)

Asthma & Respiratory
Save $30,211/mo
4× cheaper

Omalizumab injection is used to: treat asthma to treat chronic rhinosinusitis with nasal polyps (condition where inflammation of the nasal cavity and sinuses occur for 12 weeks or longer with soft, noncancerous growths) treat chronic spontaneous urticaria reduce allergic reaction after unplanned exp…

United States
$41,445
per month
India
$11,233
per month
You save
$30,211
73% cheaper in India
95.4K US scripts/yr$2.9B potential annual savings$4B US spend/yr
Compare the price
US price$41,445per month
India price$11,233per month
You save$30,21173% less

Based on 30 units per month. US $1,381.49 vs India $374.45 per unit.

Total over 1 periodSave $30,211$41,445$11,233
Is travelling to India worth it?

The savings here are large enough that a trip may still come out ahead. Adjust the numbers to your own situation — every value is an editable estimate.

Medicine savings over 6 months
$181,267
Estimated travel cost
− $2,300
Net savings after travel
$178,967

Even after travel, you could come out ahead by about $178,967.

Assumptions: medicine savings = (US − India monthly price) × months. Travel cost = flights + hotel × nights + buffer. Excludes consultation fees, visas, and other costs. For information only — not medical, legal, or travel advice.

The bigger picture

Omalizumab is filled about 95.4K times a year under Medicare Part D. At the prices above, that works out to roughly:

Est. annual US spend
$4B
If sourced from India
$1.1B
Potential annual savings
$2.9B
73%

Rough estimate. Based on Medicare Part D prescription volume (not the entire US market) scaled by the representative monthly price — actual totals depend on dose, duration and coverage.